SciSparc SPRC
NASDAQ SPRC
$4.95 -0.15 (-2.94%)
At close: Sep 9, 2026 · 4:00 PM EDT

SciSparc (SPRC) Non Operating Interest Expenses (2016 - 2022)

SciSparc's (SPRC) quarterly Non Operating Interest Expenses came in at $2.0 million in Q4 2022, up 1619.83% quarter-over-quarter from $116000.0 in Q4 2018.

Analysis

SciSparc (SPRC) Non Operating Interest Expenses (2016 - 2022) Analysis & Trends

SciSparc has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting $2.0 million for Q4 2022.

  • In Q4 2022, Non Operating Interest Expenses changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2022 stood at $2.1 million (changed N/A YoY), while the FY2025 annual figure was $8.2 million, up 2222.66% from the prior year.
  • Non Operating Interest Expenses came in at $2.0 million for Q4 2022 at SciSparc, up from $116000.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $2.0 million in Q4 2022 to a low of $1000.0 in Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 281.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 23.78 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 2.90 Mn
10 SciSparc 614,715.73 614,715.73 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.00 Mn
Dec 31, 2018 116,000.00
Sep 30, 2018 11,000.00
Jun 30, 2018 1,000.00
Mar 31, 2018 2,000.00
Dec 31, 2017 142,000.00
Sep 30, 2017 -79,000.00
Jun 30, 2017 437,000.00
Dec 31, 2016 -8,000.00
Sep 30, 2016 10,000.00